Drug Pipeline

Methylene Blue Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
1
Phase 3
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT07494773
Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection		 Phase changed: ['PHASE1', 'PHASE2'] -> ['EARLY_PHASE1']
Active Studies by Phase
Phase 2/3
1
Phase 2
1
Phase 1
1
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07264543 Early Methylene Blue in the Microhemodynamics of Septic Patients Septic Shock Recruiting
Phase 2
NCT06052956 Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses Abscess Not Yet Recruiting
Phase 1
NCT07324954 Methylene Blue in Total Knee Arthroplasty (TKA) Total Knee Arthroplasty Recruiting
Early Phase 1
NCT07435415 Local Injection Methylene Blue Combined With Radiation in HNSCC Patients Head and Neck Cancer Active, Not Recruiting
NCT07494773 Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection Burns Not Yet Recruiting
Sponsors Running Methylene Blue Trials
University of Rochester (1) Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva (1) University of Miami (1) China Medical University Hospital (1) University of Oklahoma (1)
Disease Areas
Head & Neck Cancer (1)
Get alerts when Methylene Blue trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free